Raras
Buscar doenças, sintomas, genes...
Neuropatia motora axonal, aguda (AMAN)
ORPHA:98918CID-10 · G61.0CID-11 · 8C01.0DOENÇA RARA

Neurossarcoidose se refere a um tipo de sarcoidose, uma doença imunomediada caracterizada por inflamação granulomatosa dos órgãos afectados. Granulomas epitelioides compactos, bem formados, coalescentes, não necrosantes ou minimamente necrosantes, com linfócitos dispersos, são as características patológicas da doença. Os órgãos mais frequentemente afectados incluem os pulmões (90%), a pele (∼15%), os olhos (10-30%), o fígado (20-30%) e os gânglios linfáticos (10%-20%).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A neuropatia axonal motora aguda (AMAN) é uma forma pura motora axonal do síndrome de Guillain-Barré (GBS; ver este termo).

Publicações científicas
582 artigos
Último publicado: 2026
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G61.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico582PubMed
Últimos 10 anos200publicações
Pico202245 papers
Linha do tempo
2026Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Neuropatia motora axonal, aguda (AMAN)

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
338 papers (10 anos)
#1

Patterns of Seasonality and Subtype-Linked Outcomes of Pediatric Guillain-Barré Syndrome ICU Admissions: A 10-Year Audit from Southern India.

Indian pediatrics2026 Mar

To evaluate the seasonal variation in Guillain-Barré Syndrome (GBS) subtype distribution and its association with clinical outcomes in pediatric patients requiring intensive care unit (ICU) admission. An audit of pediatric patients with GBS admitted to the neuro-ICU of a tertiary center in Southern India between 2008 and 2018 was conducted. Seasonal distribution was defined as per meteorological classification: summer (March-May), monsoon (June-September), post-monsoon (October-November), and winter (December-February). Clinical subtypes, treatment, and outcomes, including length of mechanical ventilation (LOMV), ICU stay (LOIS), hospital stay (LOHS), and Hughes disability scores, were analyzed across seasons. Among 75 patients, the highest admissions occurred during the monsoon (n = 29). Acute motor axonal neuropathy (AMAN) was more frequent in monsoon, while acute inflammatory demyelinating polyneuropathy (AIDP) was common in winter and summer. Across the full cohort, no statistically significant seasonal differences were found in the outcomes. However, within the AMAN subtype, LOHS was significantly longer in summer compared to post-monsoon (P = 0.005). Axonal variants showed higher rates of intubation and severe disability (Hughes disability score > 3), while AIDP had milder outcomes. Seasonal clustering of GBS subtypes was observed, with axonal variants more common during the monsoon. However, seasonal variation did not significantly impact the overall clinical outcomes in pediatric ICU patients.

#2

Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies.

Handbook of clinical neurology2026

Guillain-Barré syndrome (GBS) and other acute autoimmune neuropathies are rare but severe immune-mediated diseases of the peripheral nervous system. Early diagnosis is important for adequate monitoring and treatment, but it can be complicated by the rarity, heterogeneity in clinical presentation, and extensive differential diagnosis. The current proven effective treatments for GBS are intravenous immunoglobulins administered within 2 weeks and plasma exchange within 4 weeks from the onset of weakness. These therapies are immunomodulatory and aim to prevent further damage of peripheral nerves during the acute stage of the disease. Here we provide an overview of the early presentation of GBS and the required diagnostic workup to discriminate GBS from other causes, including other acute forms of autoimmune polyneuropathies. In addition, the current evidence-based immunotherapies for GBS are discussed along with the presumed pathophysiologic mechanisms of action and practical recommendations for the treatment in clinical practice. Despite current treatment, a substantial proportion of patients with GBS have a poor clinical course and outcome. We will present the latest developments regarding potential new treatments that are currently being evaluated and discuss various opportunities to optimize the design of future treatment trials toward a more effective and personalized treatment of GBS.

#3

Fine Motor Outcomes in Children with Guillain-Barré Syndrome.

Indian journal of pediatrics2026 Mar

To study the motor outcomes at 6-mo and 1-y follow-up of children with Guillain-Barré syndrome (GBS). This study was an ambispective study of 12 mo duration including children with GBS. The motor outcomes were assessed using Hughes Guillain-Barré Syndrome Disability Score (GBSDS) and Overall Neuropathy Limitations Scale (ONLS) at discharge, 6-mo, and 1-y follow-up. Of 56 patients enrolled, 52 children were included in the study. The median (IQR) age at presentation was 8 (4-11) y. Acute motor axonal neuropathy (AMAN) was the most common variant (50%) in the study. At discharge, all the children had GBSDS ≥ 2, with 51.9% (27/52) patients at 6-mo follow-up, and 19.2% (10/52) had GBSDS ≥ 2 at 1-y follow-up, signifying the need for assistance. On ONLS assessment, 46.2% (24/52) had an arm score of > 2, and 86.5% (45/52) had a leg score of > 2 at discharge. At 6-mo follow-up, 26.9% (14/52) had an arm score > 2, and 19.2% (10/52) had a leg score > 2. At 1-y follow-up, 7.7% (4/52) had an arm score of > 2, and 9.7% (5/52) had a leg score > 2. There was no mortality in the index study. Though most children with GBS recover completely, there can still be long-term impairments of fine motor movements required for daily activities. Early recognition and monitoring of persistent motor deficits as long-term sequelae of GBS is of utmost importance to improve the quality of life of these children.

#4

Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.

Pediatric neurology2026 Feb

Electrophysiological subtypes of Guillain-Barré Syndrome (GBS) vary in pathophysiology and clinical presentation, but comparative data on their intensive care needs in critically ill children remain limited. In this retrospective cohort study, we analyzed 224 children (1 month to 12 years) diagnosed with GBS and admitted to the Pediatric Intensive Care Unit of a tertiary care hospital in North India from January 2010 to December 2022. GBS was subtyped based on nerve conduction studies into acute motor axonal neuropathy (AMAN), acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor-sensory axonal neuropathy (AMSAN), inexcitable, or equivocal patterns. Clinical features, intensive care interventions, and outcomes were compared across subtypes. AMAN was the most common subtype (61.6%), followed by AIDP (20.1%) and AMSAN (8%). A prodromal illness was reported in 47.3% of cases. Mechanical ventilation was required in 54.9%, and tracheostomy in 24.2% of children. AMSAN was associated with a significantly longer duration of symptoms at presentation (P = 0.006). Autonomic instability, particularly hypertension (P = 0.04), was significantly more frequent in the AIDP group. However, Hughes disability scores, respiratory and cranial nerve involvement, and intensive care needs were similar across subtypes. AMAN was the predominant GBS subtype in critically ill children. While AMSAN was associated with delayed presentation and AIDP with greater autonomic dysfunction, overall intensive care needs and short-term outcomes were comparable across subtypes.

#5

Fusion of molecular mimicry, epigenetic predisposition, and new onset GBS: a narrative review of current understanding and future directions.

Annals of medicine and surgery (2012)2026 Feb

Guillain-Barré syndrome (GBS) is a severe immune-driven polyneuropathy marked by the acute onset of flaccid paralysis, areflexia, and in severe cases, life-threatening autonomic or respiratory failure. Although the clinical presentation and diagnostic criteria are widely established, the precise mechanisms underlying GBS are complex and poorly understood. This review summarizes current literature on the interplay of post-infectious triggers, molecular mimicry, and host susceptibility as influenced by genetic and epigenetic variables. Infectious pathogens such as Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, and, more recently, Zika and SARS-CoV-2 operate as initiators via molecular mimicry, in which pathogen antigens imitate peripheral nerve components, triggering the formation of autoreactive antibody and T-cell responses. Acute inflammatory demyelinating polyneuropathy (AIDP) is characterized by demyelination and inflammatory cytokine responses, whereas acute motor axonal neuropathy (AMAN) is associated with ganglioside-targeting antibodies and axonal loss. Genetic polymorphisms, such as those in HLA, TLR4, MMP9, and CD1A, influence vulnerability to the disease and its progression. Given that many patients experience persistent sensory, motor, and autonomic dysfunction despite treatment, the identification of long-term complications highlights the necessity of customized rehabilitation and long-term follow-up. Traditional therapeutic techniques, such as plasma exchange and intravenous immunoglobulin, remain in use, but current trials on complement inhibitors, antibody-degrading enzymes, and mesenchymal stem cell therapies indicate a move toward mechanism-driven approaches. Despite these advances, significant knowledge gaps remain regarding predictors of poor outcomes and underlying causes of persistent disabilities and complications, highlighting the need for continued translational and clinical research.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC139 artigos no totalmostrando 199

2026

Fusion of molecular mimicry, epigenetic predisposition, and new onset GBS: a narrative review of current understanding and future directions.

Annals of medicine and surgery (2012)
2026

Clinical and Electrophysiological Spectrum of Guillain-Barré Syndrome in Syria: A Prospective Cohort Study Highlighting Atypical Presentations.

Neuroepidemiology
2026

Challenges in managing prolonged intensive care unit stay for Guillain-Barré syndrome-acute motor axonal neuropathy variant.

SAGE open medical case reports
2025

Plasma exchange following immunoglobulins for Guillain-Barré-Syndrome: a persisting problematic practice?

Frontiers in neurology
2026

Patterns of Seasonality and Subtype-Linked Outcomes of Pediatric Guillain-Barré Syndrome ICU Admissions: A 10-Year Audit from Southern India.

Indian pediatrics
2026

Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies.

Handbook of clinical neurology
2026

Utility of the "Modified Erasmus GBS Respiratory Insufficiency Score" in Axonal and Demyelinating Guillain-Barré Syndrome.

Journal of the peripheral nervous system : JPNS
2025

Rapidly Progressive Guillain-Barré Syndrome (GBS) as a Critical Predictor of Early Mechanical Ventilation and Prolonged Hospitalization: An Observational Study at a Tertiary Care Hospital.

Cureus
2025

Atypical Acute Motor Axonal Neuropathy (AMAN) Presenting Concurrently With Community-Acquired Pneumonia and Respiratory Failure: A Case Report.

Cureus
2025

In cases of immunoglobulin failure in acute motor axonal neuropathy and Miller Fisher syndrome, plasma exchange should be performed early.

Internal medicine (Tokyo, Japan)
2025

Dengue virus infection and Guillain-Barré syndrome: a systematic review of clinical characteristics, outcomes, and predictors of severity.

BMC infectious diseases
2026

Fine Motor Outcomes in Children with Guillain-Barré Syndrome.

Indian journal of pediatrics
2025

Meningoencephalitis as a presentation of primary Sjögren's syndrome: a case report.

Journal of medical case reports
2026

Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.

Pediatric neurology
2025

SYK regulates Schwann cell metabolic reprogramming to promote axonal regeneration in immune-mediated neuropathy.

Journal of neuroinflammation
2025

Guillain-Barré Syndrome After Inactivated Poliovirus Vaccination: A Rare Clinical Case Report.

Annals of medicine and surgery (2012)
2025

Guillain-Barré Syndrome and Variants.

Neurologic clinics
2025

Hyperacute Guillain-Barré Syndrome Reaching Clinical Nadir Within 16 Hours: A Case Report.

Internal medicine (Tokyo, Japan)
2025

Guillain-Barré Syndrome as an Initial Manifestation of Systemic Lupus Erythematous: Rare Case Report.

Journal of investigative medicine high impact case reports
2025

Guillain-Barré Syndrome Mimicking Autoimmune Hepatitis: A Rare Entity.

ACG case reports journal
2025

DKA with negative DM-autoantibodies, complicated by GBS and RESLES: a case report and literature review.

Frontiers in immunology
2025

Neurofilament Light Chain Levels as Diagnostic and Prognostic Biomarkers in Guillain-Barré Syndrome: An Updated Systematic Review and Meta-Analysis.

Neurology and therapy
2025

Guillain-barré syndrome following brainstem infarction: a case report and pathophysiological hypothesis.

Frontiers in immunology
2025

Characterization of Autonomic Involvement in Various Subtypes of Guillain-Barré Syndrome and Association With Electrophysiological Parameters.

Muscle & nerve
2025

Guillain-Barré Syndrome Secondary to Snake Bite: A Report of a Rare and Fatal Case.

The American journal of case reports
2025

A Guillain Barre Syndrome (GBS): a case report.

International journal of emergency medicine
2025

A case report of zoster-induced Guillain-Barré syndrome: diagnostic challenges and potential role of pulse prednisone.

Annals of medicine and surgery (2012)
2025

Safety assessment of dexmedetomidine: Real-world adverse event analysis from the Food and Drug Administration Adverse Events Reporting System public dashboard.

Indian journal of pharmacology
2025

NMDA Receptors Coordinate Metabolic Reprogramming and Mitophagy in Schwann Cells to Promote Peripheral Nerve Regeneration.

Research (Washington, D.C.)
2025

Hyperreflexia and Preserved Reflexes in Pediatric Guillain-Barré Syndrome: A Case Report and Literature Review.

Cureus
2025

Plasma periaxin is a biomarker of peripheral nerve demyelination.

Brain : a journal of neurology
2025

Integrated treatment approach to Miller Fisher syndrome, a variant of Guillain-Barre syndrome - A case report.

Journal of Ayurveda and integrative medicine
2025

Serial Serum Immunoglobulin G Levels and Correlation with Outcomes in Children with Guillain Barre Syndrome.

Indian journal of pediatrics
2026

Axonal Guillain-Barré Syndrome After Leptospirosis Contracted in a Cave or While Packrafting-A Case Report.

Wilderness & environmental medicine
2025

Rapid Paralysis and Hidden Malignancy: Acute Motor Axonal Neuropathy Revealing Pleomorphic Liposarcoma.

European journal of case reports in internal medicine
2025

Evaluation and Comparison of Treatment Response and In-Hospital Prognosis of COVID-19-Related Guillain-Barre Syndrome with Non-COVID-19 Patients.

Medical journal of the Islamic Republic of Iran
2025

Clinico-epidemiological profile and prediction of outcome in children with Guillain-Barre syndrome.

Italian journal of pediatrics
2025

Guillain-Barré Syndrome Induced by Mycoplasma Pneumoniae: A Non-classical Presentation.

Cureus
2025

Evolving understanding of Guillain-Barré syndrome pathophysiology and the central role of the classical complement pathway in axonal injury.

Frontiers in neurology
2025

Guillain-Barré Syndrome During the Outbreak of Omicron in Southern China: A Multicenter Case-Control Study.

Journal of inflammation research
2025

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center.

Frontiers in neurology
2025

Critical insights for intensivists on Guillain-Barré syndrome.

Annals of intensive care
2025

SOD1-ALS mimicking an inflammatory neuropathy: a case report.

Amyotrophic lateral sclerosis & frontotemporal degeneration
2025

Clinical Characteristics and Prognostic Factors of Anti-GM1 Antibody-Positive Guillain-Barré Syndrome Spectrum Disorders in Children.

Pediatric neurology
2025

Acute Hepatic Porphyria Presenting as Guillain-Barré Syndrome: Importance of Early Recognition and Screening.

The Neurohospitalist
2025

Clinical characteristics of Guillain-Barré syndrome in Shenzhen: a retrospective study.

BMC neurology
2025

EBV and Concomitant Acute Motor and Sensory Axonal Neuropathy in a Healthy 15-Year-Old Female.

Neuropediatrics
2025

Differential diagnosis in immune checkpoint inhibitors neurotoxicity.

Journal of neurology
2025

A unique case report on campylobacter rectus infection leading to acute motor axonal neuropathy in a pediatric patient.

Radiology case reports
2025

[A case of anti-ganglioside antibody-positive Guillain-Barré syndrome with asymmetrical muscle weakness throughout the course of the disease].

Rinsho shinkeigaku = Clinical neurology
2024

Resolution of acute motor axonal neuropathy in a patient after treatment with efgartigimod: A case report.

Medicine
2025

Potential advantage of therapeutic plasma exchange over intravenous immunoglobulin in children with axonal variant of Guillain-Barré syndrome: A report of six paediatric cases.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
2024

[Epidemiological and clinical aspects of Guilain-Barré syndrome, 2012-2022].

Revista medica del Instituto Mexicano del Seguro Social
2024

A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature.

Journal of neurovirology
2024

Prognostic Value of Early Nerve Conduction Studies in Suspected Guillain-Barré Syndrome in Pediatric Age Group: An Observational Study.

Cureus
2025

Clinical characteristics and functional outcomes of pediatric Guillain-Barré syndrome admitted to the Neuro-intensive care unit: a decade-long retrospective observational study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Postpartum Guillain-Barré Syndrome Presenting as Acute Motor Axonal Neuropathy in a Young Female: A Report of a Rare Case.

Cureus
2025

Acute hepatitis A and hepatitis C co-infection triggering Guillain-Barre syndrome.

Tropical doctor
2024

Claw Hand in Acute Motor Axonal Neuropathy Variant.

The Journal of the Association of Physicians of India
2024

Temporal Pattern of Individual Neurological Function Recovery in Guillain-Barré Syndrome.

Journal of clinical medicine
2024

Guillain-Barrè Syndrome-Retrospective Analysis of Data from a Cohort of Patients Referred to a Tertiary Care Pediatric Neuromuscular Center from 2000 to 2017: Electrophysiological Findings, Outcomes, and a Brief Literature Review.

Medicina (Kaunas, Lithuania)
2024

Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database.

Frontiers in pharmacology
2025

Opisthotonic posturing in Guillian-Barre syndrome.

The International journal of neuroscience
2024

Integrated Approach to Severe Dengue Complicated by Guillain-Barré Syndrome and Multi-organ Failure.

Cureus
2024

Improvement of Functional Mobility Using a Hip-Wearable Exoskeleton Robot in Guillain-Barré Syndrome With Residual Gait Disturbance: A Case Report.

Cureus
2024

Complete genome sequence of Edwardsiella tarda strain GBS0709 isolated from a Japanese patient with the acute motor axonal neuropathy subtype of Guillain-Barré syndrome.

Microbiology resource announcements
2024

Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database.

Frontiers in pharmacology
2024

Exploring the Efficacy of Physiotherapy in Guillain-Barré Syndrome Through Virtual Reality-Based Rehabilitation: A Case Report.

Cureus
2024

Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions.

European journal of neurology
2023

AMAN with Ophthalmoparesis: A Rare Presentation.

The Journal of the Association of Physicians of India
2024

The sural-sparing pattern in clinical variants and electrophysiological subtypes of Guillain-Barré syndrome.

Arquivos de neuro-psiquiatria
2024

Acute Motor Axonal Neuropathy in Lupus Nephritis.

Cureus
2024

Guillain-Barre syndrome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report.

BMC neurology
2024

Effectiveness of Symptomatic Physiotherapy in Enhancing the Psychological Parameters of a Patient With Guillain-Barré Syndrome: A Case Report.

Cureus
2024

Antiganglioside antibody frequency in routine clinical care settings.

European journal of neurology
2024

Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review.

Acta neurologica Belgica
2024

A Rare Presentation of Non-systemic Vasculitic Neuropathy Mimicking Guillain-Barré Syndrome: A Case Report.

Cureus
2024

Rehabilitation of a Chronic Guillain-Barré Syndrome Patient With Vibratory Motor Stimulation of Dorsiflexors: A Case Report.

Cureus
2024

TREM2 deficiency impairs the energy metabolism of Schwann cells and exacerbates peripheral neurological deficits.

Cell death & disease
2024

A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy.

European journal of neurology
2024

Guillain-Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features.

Frontiers in neurology
2024

Effectiveness of Physiotherapy Intervention in Guillain Barre Syndrome: A Case Report.

Cureus
2024

A Case of Intractable Hypophosphatemia in a Patient with Guillain-Barré Syndrome and Encephalitis after SARS-CoV-2 Infection.

Endocrine, metabolic & immune disorders drug targets
2024

The pathophysiological role of endoneurial inflammatory edema in early classical Guillain-Barré syndrome.

Clinical neurology and neurosurgery
2024

Evaluating yield and utilization of ganglioside antibody testing in clinical practice.

Journal of the neurological sciences
2024

Factors Associated with Respiratory Insufficiency in Children with Guillain-Barré Syndrome.

Neuropediatrics
2023

The characteristics of Guillain-Barre syndrome in children in pre-COVID-19 and during the COVID-19 pandemic: A cross-sectional study.

Health science reports
2023

Guillain-Barré Syndrome Presenting as Symmetrical Proximal Muscle Weakness: An Atypical Presentation.

Cureus
2023

Guillain-Barré Syndrome Presenting With Masticatory Disturbance and Reduction in Bite Force.

Cureus
2023

Practice of gait training using lower-limb orthosis and body weight-supported walker for severe acute motor axonal neuropathy: a case report.

Japanese journal of comprehensive rehabilitation science
2023

Guillain-Barré Syndrome Following Hand, Foot, and Mouth Disease in an Adult Patient.

Cureus
2023

Refining the Pulmonary and Functional Competencies in a Male Patient With Guillain-Barré Syndrome.

Cureus
2022

Acute motor axonal neuropathy associated with the Pfizer SARS-CoV-2 vaccine.

Neurology perspectives
2023

Guillain-Barré Syndrome in Adults in a Decade: The Largest, Single-Center, Cross-Sectional Study From the Kingdom of Saudi Arabia.

Cureus
2023

Clinical characteristics and management outcomes of Guillain-Barré syndrome: eight-year experience at a tertiary center in jordan - a retrospective cohort study.

Annals of medicine and surgery (2012)
2023

Markedly Prolonged Latency of Patellar Tendon Reflex in a Patient With Apparent Acute Motor Axonal Neuropathy.

Journal of clinical neurology (Seoul, Korea)
2023

Relation of Neutrophil-Lymphocyte Ratio with Clinical Severity in Patients with Guillain-Barre Syndrome.

Mymensingh medical journal : MMJ
2024

Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies.

Brain pathology (Zurich, Switzerland)
2023

Immune-mediated polyneuropathy in cats: Clinical description, electrodiagnostic assessment, and treatment.

Journal of veterinary internal medicine
2023

Concurrence of Guillain-Barré syndrome and primary biliary cholangitis not related to SARS-CoV-2: Case report.

Medwave
2023

The Association of Acute Motor Axonal Neuropathy (Guillain-Barre' Syndrome Variant) with Coronavirus (SARS-Cov-2) in a Child: A Case Report.

Iranian journal of child neurology
2023

Hyperbaric oxygen therapy improves recovery at acute motor axonal neuropathy case.

Journal of neurosciences in rural practice
2023

Association between hyperCKemia and axonal degeneration in Guillain-Barré syndrome.

BMC neurology
2022

Leptomeningeal carcinomatosis presenting with acute motor axonal neuropathy.

Indian journal of cancer
2023

Concomitant Occurrence of Acute Motor Axonal Neuropathy in Systemic Lupus Erythematosus.

American journal of physical medicine & rehabilitation
2023

Guillain-Barré syndrome associated with COVID-19: A systematic review.

Brain, behavior, & immunity - health
2022

Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model.

Brain communications
2023

Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan.

Brain & development
2023

Identical late motor responses in early Guillain-Barré syndrome: A-waves and repeater F-waves.

Journal of the peripheral nervous system : JPNS
2022

Triggers of Guillain-Barré Syndrome: Campylobacter jejuni Predominates.

International journal of molecular sciences
2022

Guillain-Barré Syndrome in Northern China: A Retrospective Analysis of 294 Patients from 2015 to 2020.

Journal of clinical medicine
2022

Prognostic Significance of Serial Nerve Conduction in GB Syndrome.

Neurology India
2022

Acute motor axonal neuropathy following SARS-CoV-2 infection in the third trimester of pregnancy.

Proceedings (Baylor University. Medical Center)
2022

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy.

Scientific reports
2022

Guillain-Barré syndrome (GBS) complicated by rhabdomyolysis (RML): Case reports of 2 children and literature review.

Frontiers in pediatrics
2022

Elevated monocyte to high-density lipoprotein cholesterol ratio correlates with clinical severity in acute inflammatory demyelinating polyradiculoneuropathy patients.

Frontiers in neurology
2022

[Finger drop variant of Guillain-Barré syndrome: a case report].

Rinsho shinkeigaku = Clinical neurology
2023

Sural Sparing Pattern and Sensory Ratio as Electrodiagnostic and Prognostic Markers in Pediatric Guillain-Barré Syndrome.

Neuropediatrics
2022

Concomitant Guillain-Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis.

BMC gastroenterology
2022

[Guillain-Barré syndrome and other autoimmune neurophaties: current therapy].

Medicina
2022

Assessment of neurological sequelae and new-onset symptoms in the long-term follow-up of paediatric Guillain-Barre syndrome: A longitudinal study from India.

Journal of paediatrics and child health
2023

Prognostic Implications of Early Albuminocytological Dissociation in Guillain-Barré Syndrome.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2022

The acute motor axonal neuropathy variant of Guillain-Barré Syndrome diagnosed after ankle trauma.

Turkish journal of emergency medicine
2022

Guillain-Barré syndrome in children - High occurrence of Miller Fisher syndrome in East Asian region.

Brain & development
2022

[Guillain Barre syndrome associated with coronavac vaccine. Report of one case].

Revista medica de Chile
2022

Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.

European journal of neurology
2022

Autoimmune glial fibrillary acidic protein astrocytopathy overlapping with immunoglobulin G anti-GM1 antibody-associated acute motor axonal neuropathy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome.

Clinics (Sao Paulo, Brazil)
2022

A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy.

Cureus
2022

Lesion Localization and Prognosis Using Electrodiagnostic Studies in Facial Diplegia: A Rare Variant of Guillain-Barre Syndrome.

Cureus
2022

Nodopathies in the Early Diagnosis of Axonal Forms of Guillain-Barré Syndrome.

Frontiers in neurology
2022

Neurophysiological Aspects in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.

Frontiers in neurology
2022

Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.

Journal of Korean medical science
2022

Are Miller Fisher syndrome and CANDA due to a paranodopathy?

Journal of the neurological sciences
2022

Post malaria acute motor axonal neuropathy.

Journal of travel medicine
2022

Guillain-Barré Syndrome Related and Unrelated to COVID-19: Clinical Follow-Up in the COVID-19 Era.

Physical therapy
2022

Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports.

Frontiers in neurology
2022

Frequency of exposure to arboviruses and characterization of Guillain Barré syndrome in a clinical cohort of patients treated at a tertiary referral center in Brasília, Federal District.

Revista da Sociedade Brasileira de Medicina Tropical
2022

Collaborative studies of U.S.-China neurologists on acute motor axonal neuropathy.

Pediatric investigation
2022

[A case suspected Sensory Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis].

Rinsho shinkeigaku = Clinical neurology
2022

COVID-19-Associated Autoimmune Disease: A Rare First Case Report of Acute Motor Axonal Neuropathy Variant of Guillain-Barre Syndrome in a Woman Patient in New York City.

Cureus
2022

Guillain-Barré Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2022

Post COVID-19 vaccination Guillain-Barre syndrome: three cases.

Human vaccines & immunotherapeutics
2022

Therapeutic plasma exchange in a patient with acute motor axonal neuropathy subtype of Guillain-Barre syndrome and systemic lupus erythematosus.

Journal of clinical apheresis
2023

Predictors of Mechanical Ventilation in Guillain-Barré Syndrome with Axonal Subtypes.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2022

Multiple Cranial Nerve Enhancement in Guillain-Barre Syndrome With Clinicoradiological Dissociation.

Journal of clinical neuromuscular disease
2022

Regional Differences of Guillain-Barré Syndrome in China: From South to North.

Frontiers in aging neuroscience
2022

Electrophysiological Pattern and Predictors of Functional Outcome of Patients with Guillain Barre Syndrome at a Tertiary Care Hospital in Pakistan.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2022

Comparison of the effects of different doses of Glucocorticoids on distinct subtypes of Guillain-Barré syndrome in Southern China.

BMC neurology
2021

COVID-19 Neuromuscular Involvement in Post-Acute Rehabilitation.

Brain sciences
2021

Severe Acute Motor Axonal Neuropathy associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report.

Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)
2022

Pearls & Oy-sters: Delayed Diagnosis of Acute Motor Axonal Neuropathy With Cardiac Arrest.

Neurology
2022

Multifocal motor neuropathy occurring after acute motor axonal neuropathy: two stages of the same disease?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Protective Effect of Hyperbaric Oxygen Treatment on Axon Degeneration after Acute Motor Axonal Neuropathy.

Autoimmune diseases
2021

Electrophysiologic findings in patients with COVID-19 and quadriparesia in the northwest of Iran, A case series study and literature review.

Caspian journal of internal medicine
2021

Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.

Diabetes & metabolic syndrome
2021

Comparison of Five Different Electrophysiological Criteria for Childhood Guillain Barre Syndrome.

Annals of Indian Academy of Neurology
2021

Bilateral Facial Palsy and Hyperreflexia as the Main Clinical Presentation in Guillain-Barré Syndrome.

The American journal of case reports
2021

Perioperative Bilateral Medial Medullary Infarction With "Snake Eyes Appearance": A Case Report.

Frontiers in medicine
2021

Guillain Barre Syndrome associated with COVID-19 Infection: A Case Report.

JNMA; journal of the Nepal Medical Association
2021

Pain in acute motor axonal neuropathy.

Muscle & nerve
2021

An unusual case of acute motor axonal neuropathy (AMAN) complicating dengue fever.

Drug discoveries & therapeutics
2021

Guillain-Barré Syndrome-Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systematic Review of 33 Cases.

BioMed research international
2021

Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature.

SAGE open medical case reports
2022

Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome.

Neurological research
2021

Unclassified subtype of Guillain-Barré syndrome is associated with quick recovery.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2021

Development of Acute Inflammatory Demyelinating Polyneuropathy 11 Days after Spinal Surgery: A Case Report and Literature Review.

Case reports in medicine
2022

Costs of Guillain-Barré Syndrome in the Brazilian Federal District: the patients' perspective.

Transactions of the Royal Society of Tropical Medicine and Hygiene
2021

Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China.

Muscle & nerve
2021

Epidemiological and clinical aspects of Guillain-Barré syndrome and its variants.

Arquivos de neuro-psiquiatria
2021

Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.

BMC neurology
2021

Genetic basis of Guillain-Barre syndrome.

Journal of neuroimmunology
2021

Emerging infectious diseases, vaccines and Guillain-Barré syndrome.

Clinical & experimental neuroimmunology
2021

Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.

Neurological research
2021

Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.

Neurology and therapy
2021

Electrophysiological characteristics of patients with nitrous oxide abuse.

Neurological research
2022

Clinical and Electrophysiological Factors Predicting Prolonged Recovery in Children with Guillain-Barré Syndrome.

Indian journal of pediatrics
2021

Systematic review of cases of acute myelitis in individuals with COVID-19.

European journal of neurology
2021

Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).

Frontiers in immunology
2021

Macrophages and Autoantibodies in Demyelinating Diseases.

Cells
2021

Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.

Journal of medical virology
2021

The value of sensory nerve conduction studies in the diagnosis of Guillain-Barré syndrome.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2021

Guillain-Barre Syndrome Associated With COVID-19 Infection: A Case Report With Review of Literature.

Cureus
2021

Acute Motor Axonal Neuropathy Improvement 20 Days After Hyperbaric Oxygen Therapy.

International medical case reports journal
2021

Clinical Characteristics and Predictors of Short-Term Outcome in Mexican Adult Patients with Guillain-Barré Syndrome.

Neurology India
2021

Clinical Profile and Outcome of Guillain-Barre Syndrome in Pediatric Patients Admitted to a Tertiary Care Centre: A Retrospective Study.

Neurology India
2021

Therapeutic plasma exchange as a first-choice therapy for axonal Guillain-Barré syndrome: A case-based review of the literature (Review).

Experimental and therapeutic medicine
2021

Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barré syndrome and their correlations with clinical features.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Guillain-Barré syndrome triggered by surgery in a Chinese population: a multicenter retrospective study.

BMC neurology
2021

Changes in motor nerve excitability in acute phase Guillain-Barré syndrome.

Muscle & nerve
2021

Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective.

Journal of neurology, neurosurgery, and psychiatry
2021

Clinical Profile and Predictors of Mechanical Ventilation in Guillain-Barre Syndrome in North Indian Children.

Journal of child neurology
2020

Acute Sensory-Motor Axonal Neuropathy in a 57-Year-Old Male Presenting With Paresthesia and Distal Muscle Weakness.

Cureus
2020

Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barré Syndrome.

Frontiers in neurology
2020

Clinical characteristics of Epstein-Barr virus infection in the pediatric nervous system.

BMC infectious diseases
2021

Finger drop sign as a new variant of acute motor axonal neuropathy.

Muscle & nerve
2020

Acute Motor Axonal Neuropathy Related to COVID-19 Infection: A New Diagnostic Overview.

Journal of clinical neuromuscular disease
2020

Relapsing Pattern of Acute Motor Axonal Neuropathy.

Journal of clinical neuromuscular disease
2021

Nodal conduction block: A unifying concept.

Muscle & nerve

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Neuropatia motora axonal, aguda (AMAN).

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Neuropatia motora axonal, aguda (AMAN)

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Patterns of Seasonality and Subtype-Linked Outcomes of Pediatric Guillain-Barré Syndrome ICU Admissions: A 10-Year Audit from Southern India.
    Indian pediatrics· 2026· PMID 41569406mais citado
  2. Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies.
    Handbook of clinical neurology· 2026· PMID 41526144mais citado
  3. Fine Motor Outcomes in Children with Guillain-Barré Syndrome.
    Indian journal of pediatrics· 2026· PMID 41417155mais citado
  4. Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.
    Pediatric neurology· 2026· PMID 41389764mais citado
  5. Fusion of molecular mimicry, epigenetic predisposition, and new onset GBS: a narrative review of current understanding and future directions.
    Annals of medicine and surgery (2012)· 2026· PMID 41675728mais citado
  6. Re-evaluation of different electrophysiological criteria for Guillain-Barré syndrome in a single cohort from China.
    Front Neurol· 2026· PMID 41890796recente
  7. Clinical and Electrophysiological Spectrum of Guillain-Barré Syndrome in Syria: A Prospective Cohort Study Highlighting Atypical Presentations.
    Neuroepidemiology· 2026· PMID 41649972recente
  8. Reply to The outcome of severe Guillain-Barré syndrome  after robotic or conventional rehabilitation also depends on the triggering agent and the neurophysiological subtype.
    Eur J Transl Myol· 2026· PMID 41645681recente
  9. Challenges in managing prolonged intensive care unit stay for Guillain-Barré syndrome-acute motor axonal neuropathy variant.
    SAGE Open Med Case Rep· 2026· PMID 41625137recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98918(Orphanet)
  2. MONDO:0020349(MONDO)
  3. GARD:19602(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q4677934(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Neuropatia motora axonal, aguda (AMAN)
Compêndio · Raras BR

Neuropatia motora axonal, aguda (AMAN)

ORPHA:98918 · MONDO:0020349
CID-10
G61.0 · Síndrome de Guillain-Barré
CID-11
Início
All ages
MedGen
UMLS
C3890941
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades